CD163 and COVID-19: Upon bacterial challenge, classical monocytes from COVID-19 patients (acute- and rec-phase) displayed high expression of CD163 and CD11b, but low expression of the activation markers HLA-DR, CD86 and CD80 (Fig 6A–6D and S8A Fig).